Clinical Trial Update: Apnex Clinical Study of the Hypoglossal Nerve Stimulation (HGNS®) System to Treat Obstructive Sleep Apnea [Phase 3]

View source ↗

Summary

A Phase 3 study of the Hypoglossal Nerve Stimulation (HGNS) system for obstructive sleep apnea was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Hypoglossal Nerve Stimulation (HGNS) System

Snippet

Sponsor: Apnex Medical, Inc. | Conditions: Obstructive Sleep Apnea | Phase 3 | Status: TERMINATED